Request Demo
Last update 21 Aug 2025
Teriparatide biosimilar (Hebang Biotechnology)
Last update 21 Aug 2025
Overview
Basic Info
Drug Type Recombinant polypeptide, Biosimilar |
Synonyms HB-1082, HB1082 |
Target |
Action agonists, stimulants |
Mechanism PTH1R agonists(Parathyroid hormone receptor agonists), Osteogenesis stimulants, Parathyroid hormone replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseNDA/BLA |
First Approval Date- |
Regulation- |
Login to view timeline
Structure/Sequence
Sequence Code 4953
The sequence is quoted from: *****
Related
1
Clinical Trials associated with Teriparatide biosimilar (Hebang Biotechnology)CTR20202278
HB1082与复泰奥在中国健康受试者中的单中心、随机、双盲、两周期、交叉、单次皮下给药的药代动力学和安全性比对研究
[Translation] A single-center, randomized, double-blind, two-period, crossover, single subcutaneous pharmacokinetic and safety comparison study of HB1082 and Futaio in Chinese healthy subjects
100 Clinical Results associated with Teriparatide biosimilar (Hebang Biotechnology)
Login to view more data
100 Translational Medicine associated with Teriparatide biosimilar (Hebang Biotechnology)
Login to view more data
100 Patents (Medical) associated with Teriparatide biosimilar (Hebang Biotechnology)
Login to view more data
100 Deals associated with Teriparatide biosimilar (Hebang Biotechnology)
Login to view more data
External Link
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Osteoporosis, Postmenopausal | NDA/BLA | China | 16 Aug 2022 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free